Patents by Inventor Andrew W. Hinman

Andrew W. Hinman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-HETEROCYCLYLAMINOALKYL-(P-QUINONE) DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
    Publication number: 20140323509
    Abstract: Methods of treating or suppressing oxidative stress disorders including mitochondrial diseases, impaired energy processing disorders, neurodegenerative diseases and diseases of aging are disclosed, as well as compounds useful in the methods of the invention, such as 2-heterocyclylaminoalkyl-(p-quinone) derivatives.
    Type: Application
    Filed: March 24, 2014
    Publication date: October 30, 2014
    Applicant: Edison Pharmaceuticals, Inc.
    Inventors: Andrew W. HINMAN, Orion D. JANKOWSKI, Kieron E. WESSON
  • PHENAZINE-3-ONE AND PHENOTHIAZINE-3-ONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS
    Publication number: 20140275045
    Abstract: Disclosed herein are phenazine-3-one and phenothiazine-3-one derivative compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases of aging.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Applicant: EDISON PHARMACEUTICALS, INC.
    Inventors: Andrew W. HINMAN, Dana Davis, William D. Shrader
  • RESORUFIN DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS
    Publication number: 20140275054
    Abstract: Disclosed herein are resorufin derivative compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases of aging.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Applicant: Edison Pharmaceuticals, Inc.
    Inventors: Andrew W. HINMAN, Dana Davis, William D. Shrader
  • RESORCINOL COMPOUNDS FOR DERMATOLOGICAL USE
    Publication number: 20140256830
    Abstract: Provided herein are methods and compositions comprising resorcinol derivatives for the use of treating, regulating or preventing a skin condition characterized by oxidative stress or a degenerative process. Methods of preventing, lightening or reducing the appearance of visible discontinuities of the skin resulting from skin pigmentation, skin aging, or other disorders are also disclosed.
    Type: Application
    Filed: March 6, 2014
    Publication date: September 11, 2014
    Inventors: Andrew W. HINMAN, Dana Davis, Viktoria Kheifets
  • PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES
    Publication number: 20140221674
    Abstract: The invention discloses novel processes for production, enrichment and/or isolation of alpha-tocotrienol from source material comprising at least one non-alpha-tocotrienol, such as natural extracts comprising mixed tocotrienols.
    Type: Application
    Filed: September 26, 2013
    Publication date: August 7, 2014
    Applicant: Edison Pharmaceuticals, Inc.
    Inventors: Kieron E. Wesson, Andrew W. Hinman, Orion D. Jankowski
  • 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
    Patent number: 8716486
    Abstract: Methods of treating or suppressing oxidative stress disorders including mitochondrial diseases, impaired energy processing disorders, neurodegenerative diseases and diseases of aging are disclosed, as well as compounds useful in the methods of the invention, such as 2-heterocyclylaminoalkyl-(p-quinone) derivatives.
    Type: Grant
    Filed: June 23, 2009
    Date of Patent: May 6, 2014
    Assignee: Edison Pharmaceuticals, Inc.
    Inventors: Andrew W. Hinman, Orion D. Jankowski, Kieron E. Wesson
  • 2-substituted--quinone derivatives for treatment of oxidative stress diseases
    Patent number: 8716527
    Abstract: Methods of treating or suppressing oxidative stress diseases including mitochondrial diseases, impaired energy processing disorders, neurodegenerative diseases and diseases of aging are disclosed, as well as compounds useful in the methods of the invention, such as 2- substituted-p-quinone derivatives as disclosed herein.
    Type: Grant
    Filed: March 4, 2009
    Date of Patent: May 6, 2014
    Assignee: Edison Pharmaceuticals, Inc.
    Inventors: Andrew W. Hinman, Kieron E. Wesson, Orion D. Jankowski, Paul Mollard, William D. Shrader, Christopher R. Cornell
  • TREATMENT OF MITOCHONDRIAL DISEASES WITH VITAMIN K
    Publication number: 20140031432
    Abstract: Methods of treating, preventing or suppressing symptoms associated with mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), dominant optic atrophy (DOA); mitochondrial myopathy, encephalopathy, lactacidosis, stroke (MELAS), Leigh syndrome or Kearns-Sayre Syndrome (KSS) with vitamin K are disclosed.
    Type: Application
    Filed: August 4, 2011
    Publication date: January 30, 2014
    Applicant: Ampere Life Sciences, Inc.
    Inventors: Orion D. Jankowski, Andrew W. Hinman, Guy M. Miller
  • TREATMENT OF MITOCHONDRIAL DISEASES WITH NAPHTHOQUINONES
    Publication number: 20130345312
    Abstract: Methods of treating, preventing or suppressing symptoms associated with mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), dominant optic atrophy (DOA); mitochondrial myopathy, encephalopathy, lactacidosis, stroke (MELAS), Leigh syndrome or Kearns-Sayre Syndrome (KSS) with compounds of Formula (I) are disclosed. Methods of modulating, normalizing, or enhancing energy biomarkers, as well as compounds useful for such methods are also disclosed.
    Type: Application
    Filed: August 4, 2011
    Publication date: December 26, 2013
    Inventors: Orion D. Jankowski, Andrew W. Hinman, Guy M. Miller
  • Process for the production of alpha-tocotrienol and derivatives
    Patent number: 8575369
    Abstract: The invention discloses novel processes for production, enrichment and/or isolation of alpha-tocotrienol from source material comprising at least one non-alpha-tocotrienol, such as natural extracts comprising mixed tocotrienols.
    Type: Grant
    Filed: January 25, 2012
    Date of Patent: November 5, 2013
    Assignee: Edison Pharmaceuticals, Inc.
    Inventors: Kieron E. Wesson, Andrew W. Hinman, Orion D. Jankowski
  • PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES
    Publication number: 20120130093
    Abstract: The invention discloses novel processes for production, enrichment and/or isolation of alpha-tocotrienol from source material comprising at least one non-alpha-tocotrienol, such as natural extracts comprising mixed tocotrienols.
    Type: Application
    Filed: January 25, 2012
    Publication date: May 24, 2012
    Inventors: Kieron E. WESSON, Andrew W. Hinman, Orion D. Jankowski
  • Process for the production of alpha-tocotrienol and derivatives
    Patent number: 8106223
    Abstract: The invention discloses novel processes for production, enrichment and/or isolation of alpha-tocotrienol from source material comprising at least one non-alpha-tocotrienol, such as natural extracts comprising mixed tocotrienols.
    Type: Grant
    Filed: October 27, 2009
    Date of Patent: January 31, 2012
    Assignee: Edison Pharmaceuticals, Inc.
    Inventors: Kieron E. Wesson, Andrew W. Hinman, Orion D. Jankowski
  • 2-HETEROCYCLYLAMINOALKYL-(P-QUINONE) DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
    Publication number: 20110218208
    Abstract: Methods of treating or suppressing oxidative stress disorders including mitochondrial diseases, impaired energy processing disorders, neurodegenerative diseases and diseases of aging are disclosed, as well as compounds useful in the methods of the invention, such as 2-heterocyclylaminoalkyl-(p-quinone) derivatives.
    Type: Application
    Filed: June 23, 2009
    Publication date: September 8, 2011
    Inventors: Andrew W. Hinman, Orion D. Jankowski, Kieron E. Wesson
  • 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
    Publication number: 20110124679
    Abstract: Methods of treating or suppressing oxidative stress diseases including mitochondrial diseases, impaired energy processing disorders, neurodegenerative diseases and diseases of aging are disclosed, as well as compounds useful in the methods of the invention, such as 2-substituted-p-quinone derivatives as disclosed herein.
    Type: Application
    Filed: March 4, 2009
    Publication date: May 26, 2011
    Inventors: Andrew W. Hinman, Kieron E. Wesson, Orion D. Jankowski, Paul Mollard, William D. Shrader, Christpher R. Cornell
  • PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES
    Publication number: 20100105930
    Abstract: The invention discloses novel processes for production, enrichment and/or isolation of alpha-tocotrienol from source material comprising at least one non-alpha-tocotrienol, such as natural extracts comprising mixed tocotrienols.
    Type: Application
    Filed: October 27, 2009
    Publication date: April 29, 2010
    Inventors: Kieron E. WESSON, Andrew W. Hinman, Orion D. Jankowski
  • NAPHTHOQUINONE COMPOSITIONS WITH ANTI-AGING, ANTI-INFLAMMATORY AND SKIN EVEN-TONING PROPERTIES
    Publication number: 20100029784
    Abstract: The present invention relates to methods and compositions comprising naphthoquinones such as 2,3-dimethylnaphthalene-1,4-dione, for the use of treating, regulating or preventing a skin condition characterized by oxidative stress or a degenerative process. Methods of preventing, lightening or reducing the appearance of visible and/or tactile discontinuities of the skin resulting from skin pigmentation or skin aging are also disclosed.
    Type: Application
    Filed: July 7, 2009
    Publication date: February 4, 2010
    Inventors: Andrew W. Hinman, Guy M. Miller
  • DERMATOLOGICAL COMPOSITIONS WITH ANTI-AGING AND SKIN EVEN-TONING PROPERTIES
    Publication number: 20100010100
    Abstract: The present invention relates to methods and compositions comprising benzoquinones such as Duroquinone, for the use of treating, regulating or preventing a skin condition characterized by oxidative stress or a degenerative process. Methods of preventing, lightening or reducing the appearance of visible and/or tactile discontinuities of the skin resulting from skin pigmentation or skin aging are also disclosed.
    Type: Application
    Filed: July 7, 2009
    Publication date: January 14, 2010
    Inventors: Andrew W. Hinman, Guy M. Miller